Aridis Pharmaceuticals, Inc.
Targets of Acinetobacter Baumannii

Last updated:

Abstract:

The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Status:
Grant
Type:

Utility

Filling date:

14 Feb 2018

Issue date:

3 Sep 2019